Akshay Vaishnaw, President, R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 1,304 shares at $152.22 ($197K) on 2020-06-22, disclosed to the SEC on 2020-06-24.
Seasonal sale ($197k) by President, R&D — this insider has traded ALNY in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.48 | 178 | $26K | 13.4% |
| 2 | $149.09 | 83 | $12K | 6.3% |
| 3 | $150.34 | 180 | $27K | 13.7% |
| 4 | $152.22 | 334 | $51K | 25.8% |
| 5 | $152.22 | 334 | $51K | 25.8% |
| 6 | $152.97 | 195 |
| $30K |
| 15.1% |
| Total | $151.36 avg | 1,304 | $197K | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |